These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24918556)

  • 1. Safety and efficacy comparison of minocycline microgranules vs lymecycline in the treatment of mild to moderate acne: randomized, evaluator-blinded, parallel, and prospective clinical trial for 8 weeks.
    Ocampo-Candiani J; Velazquez-Arenas LL; de la Fuente-Garcia A; Trevino-Gomezharper C; Berber A
    J Drugs Dermatol; 2014 Jun; 13(6):671-6. PubMed ID: 24918556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline.
    Bossuyt L; Bosschaert J; Richert B; Cromphaut P; Mitchell T; Al Abadie M; Henry I; Bewley A; Poyner T; Mann N; Czernielewski J
    Eur J Dermatol; 2003; 13(2):130-5. PubMed ID: 12695127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy.
    Piérard-Franchimont C; Goffin V; Arrese JE; Martalo O; Braham C; Slachmuylders P; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 2002; 15(2):112-9. PubMed ID: 11867968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens.
    Dubertret L; Alirezai M; Rostain G; Lahfa M; Forsea D; Niculae BD; Simola M; Horvath A; Mizzi F
    Eur J Dermatol; 2003; 13(1):44-8. PubMed ID: 12609781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle.
    Cunliffe WJ; Meynadier J; Alirezai M; George SA; Coutts I; Roseeuw DI; Hachem JP; Briantais P; Sidou F; Soto P
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S218-26. PubMed ID: 12963898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline.
    Alirezai M; George SA; Coutts I; Roseeuw DI; Hachem JP; Kerrouche N; Sidou F; Soto P
    Eur J Dermatol; 2007; 17(1):45-51. PubMed ID: 17324827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.
    Gruber F; Grubisić-Greblo H; Kastelan M; Brajac I; Lenković M; Zamolo G
    J Chemother; 1998 Dec; 10(6):469-73. PubMed ID: 9876055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
    Leyden JJ; Bruce S; Lee CS; Ling M; Sheth PB; Stewart DM; Werschler WP; Gilbert RD; Kircik L
    J Drugs Dermatol; 2013 Jun; 12(6):658-63. PubMed ID: 23839182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne.
    Jung GW; Tse JE; Guiha I; Rao J
    J Cutan Med Surg; 2013; 17(2):114-22. PubMed ID: 23582165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB; Dinehart S; Stough D; Plott RT; ;
    Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
    Raoof TJ; Hooper D; Moore A; Zaiac M; Sullivan T; Kircik L; Lain E; Jankicevic J; Stuart I
    J Am Acad Dermatol; 2020 Apr; 82(4):832-837. PubMed ID: 31163231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.